Related Experiment Video
Updated: Aug 7, 2026

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
Published on: February 16, 2015
Janus kinase-2 signaling mediates apoptosis in rat cardiomyocytes
Eduardo Mascareno1, Daniel L Beckles, M A Q Siddiqui
1Center for Cardiovascular and Muscle Research, Department of Anatomy and Cell Biology, State University of New York Downstate Medical Center, 450 Clarkson Avenue, Brooklyn, N.Y. 11203, USA.
Abstract:
We tested the hypothesis that activation Jak2, which is prominently involved in the up-regulation of the renin-angiotensin system (RAS), constitutes a focal point in relaying signals triggered by a Angiotensin II (Ang II) and hypoxia/reoxygenation separately to cause an enhanced susceptibility of cardiac myocyte to apoptotic cell death. Ang II-treated adult cardiomyocytes in culture exhibited an increased level of apoptosis that accompanied activation of pro-apoptotic as well as anti-apoptotic signaling pathways. We observed increased phosphorylation of Jak2 kinase, Stat1, JNK, with increased expression of Bax protein, followed by an increase in caspase-1 and caspase-3 activity. Activation of these pro-apoptotic pathways was blocked by the Jak2 pharmacological inhibitor, Tyrphostin AG490. We also observed an increase in phosphorylation of cardioprotective pathway components, namely S6 ribosomal protein, and heat shock protein 27 (HSP27). Likewise, the oxidative stress, via the hypoxia/reoxygenation treatment of rat adult cardiomyocytes, produced apoptosis that was dependent upon activation of Jak2. The apoptotic response was not only reduced by Losartan, an inverse agonist of the AT1, receptor, but by treatment with AG490 as well. Taken together, these observations provide clear evidence in favor of Jak2 signaling as mediator of the apoptotic response in cardiomyocytes. However, there was a concomitant induction of cytoprotective signaling that presumably provides a negative feed-back to the deleterious effects of the agonist.
Insights
Janus kinase 2 (Jak2) signaling mediates cardiac myocyte apoptosis induced by Angiotensin II and hypoxia/reoxygenation. Inhibiting Jak2 with Tyrphostin AG490 blocked these apoptotic pathways, suggesting Jak2 as a therapeutic target.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Cell Death Signaling
Background:
- The renin-angiotensin system (RAS) plays a crucial role in cardiovascular regulation.
- Angiotensin II (Ang II) and oxidative stress contribute to cardiac myocyte apoptosis.
- Janus kinase 2 (Jak2) is implicated in signaling pathways relevant to cardiovascular disease.
Purpose of the Study:
- To investigate the role of Jak2 activation in mediating apoptosis of cardiac myocytes induced by Angiotensin II (Ang II) and hypoxia/reoxygenation.
- To determine if Jak2 acts as a central mediator for signals leading to enhanced cardiomyocyte susceptibility to cell death.
- To explore the impact of Jak2 inhibition on pro-apoptotic and anti-apoptotic signaling pathways in cardiomyocytes.
Main Methods:
- Adult rat cardiomyocytes were treated with Ang II or subjected to hypoxia/reoxygenation.
- Western blotting was used to assess protein phosphorylation and expression (Jak2, Stat1, JNK, Bax, S6 ribosomal protein, HSP27).
- Caspase-1 and caspase-3 activities were measured.
- Pharmacological inhibitors (Tyrphostin AG490 for Jak2, Losartan for AT1 receptor) were employed.
Main Results:
- Ang II treatment induced cardiomyocyte apoptosis, increased pro-apoptotic markers (phosphorylated Jak2, Stat1, JNK, Bax), and activated caspases.
- Hypoxia/reoxygenation also triggered apoptosis dependent on Jak2 activation.
- The Jak2 inhibitor Tyrphostin AG490 significantly reduced apoptosis and downstream signaling in both models.
- Losartan also attenuated the apoptotic response to hypoxia/reoxygenation.
- Cardioprotective pathways involving S6 ribosomal protein and HSP27 were concurrently activated.
Conclusions:
- Jak2 signaling is a critical mediator of Angiotensin II- and hypoxia/reoxygenation-induced apoptosis in cardiac myocytes.
- Pharmacological inhibition of Jak2 effectively blocks these apoptotic pathways, highlighting its potential as a therapeutic target.
- While Jak2 activation promotes apoptosis, there is a concurrent activation of cytoprotective signaling pathways that may serve as a negative feedback mechanism.
More Related Videos
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Related Concept Videos
Apoptosis
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway